Director Berg sells 49.4K ORCL shares ($14.0M) in 4 transactions; stock down 21.8% from 52-week high.
Jeffrey Berg (Director) executed 4 separate sales totaling 49,365 shares for $13,971,266.67 on 2025-10-28, reducing his holdings from 201,364 to 151,999 shares (-24.5%). The blended average sale price was $283.02, while the current price stands at $256.89, representing a 21.8% decline from the 52-week high of $328.33. Notably, his prior sales at ORCL show a consistent pattern: 0 of 5 prior sells were well-timed at the 90-day mark (average 90d return +12.6%, meaning he sold before subsequent gains). The transaction occurred as Oracle trades at a P/E of 58.65 with recent quarterly fundamentals showing $14.9B in revenue and $2.9B in net income. The absence of a 10b5-1 plan flag indicates this was a discretionary sale.
Director Jeffrey Berg sells 22,500 ORCL shares for $3.2M at blended avg $143.12; holdings drop 9.6% to 210.7K shares
Jeffrey Berg, a Director at Oracle, executed two separate sales on 2024-06-20 totaling 22,500 shares for $3,220,115.69 at a blended average price of $143.12, reducing his holdings from 233.2K to 210.7K shares. The sales occurred near Oracle's 52-week high of $144.64, with the stock trading at +13.6% over 30 days and +10.7% over 90 days at the time of the transaction. Berg's prior ORCL sales (three trades on record) showed a 0% well-timed rate at the 90-day mark, with mixed outcomes: two March 2024 sales preceded modest declines (-7.1% and -7.5% at 30 days), while a 2023 sale was followed by strong gains (+27.2% at 90 days). His cross-ticker sell history shows an average 90-day return of +14.3% after sales—indicating his past sales have generally preceded stock appreciation rather than declines.
